Clinical correlates do not predict PaO2 response after tolazoline administration in hypoxic newborns.
In an attempt to determine which hypoxic newborns might benefit from administration of tolazoline hydrochloride (Tz), we identified all neonates known to have received Tz at four Chicago area perinatal centers over a 4-yr period. For each of 41 infants, five statistical analyses were used to correlate 31 clinical and ventilatory variables with PaO2 values before and after Tz administration. Fourteen neonates responded to Tz infusion with more than a two-fold increase in PaO2. None of 31 clinical variables successfully predicted a positive Tz response in these infants, and a positive response (increased PaO2) was not associated with increased likelihood of survival. BP fell after Tz in 72% of patients, while heart rate rose after Tz treatment in 66% of cases. These data suggest a need to re-evaluate the administration of Tz to hypoxic newborn infants.
W
W
Meadow
A
A
Benn
N
N
Giardini
J
J
Hageman
S
S
Berger
D001794:Blood Pressure / Q000187:drug effects; D006801:Humans; D000860:Hypoxia / Q000503:physiopathology*; D007231:Infant, Newborn; D010100:Oxygen / Q000097:blood*; D010313:Partial Pressure; D010547:Persistent Fetal Circulation Syndrome / Q000188:drug therapy / Q000503:physiopathology; D011015:Pneumonia, Aspiration / Q000188:drug therapy; D011659:Pulmonary Gas Exchange / Q000187:drug effects*; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy; D014043:Tolazoline / Q000627:therapeutic use*
D014043:Tolazoline; D010100:Oxygen